{
    "xml": "<topic id=\"PHP6586\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/hydroxychloroquine-sulfate\" basename=\"hydroxychloroquine-sulfate\" title=\"HYDROXYCHLOROQUINE SULFATE\">\n<title>HYDROXYCHLOROQUINE SULFATE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_982\" namespace=\"/interactions/list-of-drug-interactions/antimalarials/hydroxychloroquine\">Hydroxychloroquine</xref>\n</p>\n<data name=\"vtmid\">83490000</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_589232130\" title=\"4-Aminoquinolines\">4-Aminoquinolines</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n<data name=\"secondaryDomainsOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP47960\" outputclass=\"indicationsAndDose\" rev=\"1.14\" parent=\"/drugs/hydroxychloroquine-sulfate\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Active rheumatoid arthritis (including juvenile idiopathic arthritis) (administered on expert advice)</p>\n<p outputclass=\"therapeuticIndication\">Systemic and discoid lupus erythematosus (administered on expert advice)</p>\n<p outputclass=\"therapeuticIndication\">Dermatological conditions caused or aggravated by sunlight (administered on expert advice)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>200&#8211;400&#8239;mg daily, daily maximum dose to be based on ideal body-weight; maximum 6.5&#8239;mg/kg per day.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49134\" outputclass=\"cautions\" rev=\"1.24\" parent=\"/drugs/hydroxychloroquine-sulfate\">\n<title>Cautions</title>\n<body>\r\n<section outputclass=\"cautions\">\r\n<p>\r\n<ph outputclass=\"caution\">\r\n<xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>\r\n</ph>; <ph outputclass=\"caution\">elderly</ph>; <ph outputclass=\"caution\">G6PD deficiency</ph>; <ph outputclass=\"caution\">may aggravate myasthenia gravis</ph>; <ph outputclass=\"caution\">may exacerbate psoriasis</ph>; <ph outputclass=\"caution\">neurological disorders (especially in those with a history of epilepsy)</ph>; <ph outputclass=\"caution\">severe gastro-intestinal disorders</ph>\r\n</p>\r\n </section>\r\n<section outputclass=\"importantAdvice\">\r\n<title>Cautions, further information</title>\r\n<sectiondiv>\r\n<p outputclass=\"title\">Screening for ocular toxicity</p>\r\n<p>A review group convened by the Royal College of Ophthalmologists has updated guidelines for screening to prevent ocular toxicity on long-term treatment with chloroquine and hydroxychloroquine (<i>Hydroxychloroquine and Ocular Toxicity: Recommendations on Screening 2009</i>). The following recommendations relate to hydroxychloroquine, which is only rarely associated with toxicity.</p>\r\n<p>\r\n<i>Before treatment</i>:</p>\r\n<ul>\r\n<li>Assess renal and liver function (adjust dose if impaired)</li>\r\n<li>Ask patient about visual impairment (not corrected by glasses). If impairment or eye disease present, assessment by an optometrist is advised and any abnormality should be referred to an ophthalmologist</li>\r\n<li>Record near visual acuity of each eye (with glasses where appropriate) using a standard reading chart</li>\r\n<li>Initiate hydroxychloroquine treatment if no abnormality detected (at a dose not exceeding hydroxychloroquine sulfate 6.5&#8239;mg/kg daily)</li>\r\n</ul>\r\n<p>\r\n<i>During treatment:</i>\r\n</p>\r\n<ul>\r\n<li>Ask patient about visual symptoms and monitor visual acuity annually using the standard reading chart</li>\r\n<li>Refer to ophthalmologist if visual acuity changes or if vision blurred and warn patient to seek prescribing doctor&#8217;s advice about stopping treatment</li>\r\n<li>If long-term treatment is required (more than 5 years), individual arrangement should be agreed with the local ophthalmologist</li>\r\n</ul>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP47865\" outputclass=\"interactions\" rev=\"1.12\" parent=\"/drugs/hydroxychloroquine-sulfate\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (chloroquine and hydroxychloroquine).</p>\n<p>Concurrent use of hepatotoxic drugs should be avoided.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP37885\" outputclass=\"sideEffects\" rev=\"1.31\" parent=\"/drugs/hydroxychloroquine-sulfate\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Gastro-intestinal disturbances</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">pruritus</ph>; <ph outputclass=\"sideEffect\">rashes</ph>; <ph outputclass=\"sideEffect\">skin reactions</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Convulsions</ph>; <ph outputclass=\"sideEffect\">discoloration of skin, nails, and mucous membranes</ph>; <ph outputclass=\"sideEffect\">ECG changes</ph>; <ph outputclass=\"sideEffect\">hair depigmentation</ph>; <ph outputclass=\"sideEffect\">hair loss</ph>; <ph outputclass=\"sideEffect\">keratopathy</ph>; <ph outputclass=\"sideEffect\">ototoxicity</ph>; <ph outputclass=\"sideEffect\">retinal damage</ph>; <ph outputclass=\"sideEffect\">visual changes</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Acute generalised exanthematous pustulosis</ph>; <ph outputclass=\"sideEffect\">agranulocytosis</ph>; <ph outputclass=\"sideEffect\">angioedema</ph>; <ph outputclass=\"sideEffect\">aplastic anaemia</ph>; <ph outputclass=\"sideEffect\">blood disorders</ph>; <ph outputclass=\"sideEffect\">cardiomyopathy</ph>; <ph outputclass=\"sideEffect\">emotional disturbances</ph>; <ph outputclass=\"sideEffect\">exfoliative dermatitis</ph>; <ph outputclass=\"sideEffect\">hepatic damage</ph>; <ph outputclass=\"sideEffect\">mental changes</ph>; <ph outputclass=\"sideEffect\">myopathy</ph>; <ph outputclass=\"sideEffect\">neuromyopathy</ph>; <ph outputclass=\"sideEffect\">photosensitivity</ph>; <ph outputclass=\"sideEffect\">psychosis</ph>; <ph outputclass=\"sideEffect\">Stevens-Johnson syndrome</ph>; <ph outputclass=\"sideEffect\">thrombocytopenia</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Bronchospasm</ph>; <ph outputclass=\"sideEffect\">diffuse parenchymal lung disease</ph>; <ph outputclass=\"sideEffect\">drug rash with eosinophilia and systemic symptoms</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsOverdosageInformation\">\n<title>Overdose</title>\n<sectiondiv>\n<p>Hydroxychloroquine is very toxic in overdosage; overdosage is extremely hazardous and difficult to treat. Urgent advice from the National Poisons Information Service is essential. Life-threatening features include arrhythmias (which can have a very rapid onset) and convulsions (which can be intractable).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP47657\" outputclass=\"pregnancy\" parent=\"/drugs/hydroxychloroquine-sulfate\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>It is not necessary to withdraw an antimalarial drug during pregnancy if the rheumatic disease is well controlled; however, the manufacturer of hydroxychloroquine advises avoiding use.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49339\" outputclass=\"breastFeeding\" parent=\"/drugs/hydroxychloroquine-sulfate\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Present in breast milk and breast-feeding; should be avoided when they are used to treat rheumatic disease.</p>\n<p>Avoid&#8212;risk of toxicity in infant.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP48133\" outputclass=\"hepaticImpairment\" parent=\"/drugs/hydroxychloroquine-sulfate\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Caution in moderate to severe hepatic impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP47368\" outputclass=\"renalImpairment\" parent=\"/drugs/hydroxychloroquine-sulfate\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises caution.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"additionalMonitoringInRenalImpairment\">\n<sectiondiv>\n<p>Monitoring of plasma-hydroxychloroquine concentration in severe renal impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP37643\" outputclass=\"monitoringRequirements\" parent=\"/drugs/hydroxychloroquine-sulfate\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Manufacturers recommend regular ophthalmological examination but the evidence of practical value is unsatisfactory (see advice of the Royal College of Ophthalmologists).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP60913\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.10\" parent=\"/drugs/hydroxychloroquine-sulfate\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>To avoid excessive dosage in obese patients, the dose of hydroxychloroquine should be calculated on the basis of ideal body-weight.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP47543\" outputclass=\"patientAndCarerAdvice\" rev=\"1.9\" parent=\"/drugs/hydroxychloroquine-sulfate\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"generalPatientAdvice\">\n<sectiondiv>\n<p>Do not take antacids for at least 4 hours before or after hydroxychloroquine to reduce possible interference with hydroxychloroquine absorption.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP6586-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/hydroxychloroquine-sulfate\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral solution, oral suspension</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76794\" title=\"Tablet\" namespace=\"/drugs/hydroxychloroquine-sulfate/tablet\">Tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78421\" namespace=\"/treatment-summaries/rheumatic-disease-suppressing-drugs\" title=\"Rheumatic disease, suppressing drugs\" count=\"5\" rel=\"backlink\">Rheumatic disease, suppressing drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78455\" namespace=\"/treatment-summaries/corticosteroids-inflammatory-disorders\" title=\"Corticosteroids, inflammatory disorders\" count=\"1\" rel=\"backlink\">Corticosteroids, inflammatory disorders</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78614\" namespace=\"/treatment-summaries/arthritis\" title=\"Arthritis\" count=\"1\" rel=\"backlink\">Arthritis</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_982\" namespace=\"/interactions/list-of-drug-interactions/antimalarials/hydroxychloroquine\" title=\"Hydroxychloroquine\" count=\"1\" rel=\"link\">Hydroxychloroquine</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78608\" namespace=\"/treatment-summaries/acute-porphyrias\" title=\"Acute porphyrias\" count=\"1\" rel=\"link\">Acute porphyrias</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76794\" namespace=\"/drugs/hydroxychloroquine-sulfate/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n</links>\n</topic>",
    "id": "PHP6586",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/hydroxychloroquine-sulfate",
    "basename": "hydroxychloroquine-sulfate",
    "title": "HYDROXYCHLOROQUINE SULFATE",
    "interactants": [
        {
            "id": "bnf_int_982",
            "label": "Hydroxychloroquine"
        }
    ],
    "vtmid": "83490000",
    "drugClassification": [
        "4-Aminoquinolines"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "secondaryDomainsOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Active rheumatoid arthritis (including juvenile idiopathic arthritis) (administered on expert advice)",
                        "html": "Active rheumatoid arthritis (including juvenile idiopathic arthritis) (administered on expert advice)"
                    },
                    {
                        "textContent": "Systemic and discoid lupus erythematosus (administered on expert advice)",
                        "html": "Systemic and discoid lupus erythematosus (administered on expert advice)"
                    },
                    {
                        "textContent": "Dermatological conditions caused or aggravated by sunlight (administered on expert advice)",
                        "html": "Dermatological conditions caused or aggravated by sunlight (administered on expert advice)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "200&#8211;400 mg daily, daily maximum dose to be based on ideal body-weight; maximum 6.5 mg/kg per day.",
                        "html": "<p>200&#8211;400&#8239;mg daily, daily maximum dose to be based on ideal body-weight; maximum 6.5&#8239;mg/kg per day.</p>"
                    }
                ]
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Acute porphyrias",
                "html": "<xref format=\"dita\" href=\"#PHP78608\" type=\"bookmark\" namespace=\"/treatment-summaries/acute-porphyrias\">Acute porphyrias</xref>",
                "references": [
                    {
                        "id": "PHP78608",
                        "label": "Acute porphyrias"
                    }
                ]
            },
            {
                "type": "cautions",
                "textContent": "elderly",
                "html": "elderly"
            },
            {
                "type": "cautions",
                "textContent": "G6PD deficiency",
                "html": "G6PD deficiency"
            },
            {
                "type": "cautions",
                "textContent": "may aggravate myasthenia gravis",
                "html": "may aggravate myasthenia gravis"
            },
            {
                "type": "cautions",
                "textContent": "may exacerbate psoriasis",
                "html": "may exacerbate psoriasis"
            },
            {
                "type": "cautions",
                "textContent": "neurological disorders (especially in those with a history of epilepsy)",
                "html": "neurological disorders (especially in those with a history of epilepsy)"
            },
            {
                "type": "cautions",
                "textContent": "severe gastro-intestinal disorders",
                "html": "severe gastro-intestinal disorders"
            }
        ],
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "title": "Screening for ocular toxicity",
                "textContent": "A review group convened by the Royal College of Ophthalmologists has updated guidelines for screening to prevent ocular toxicity on long-term treatment with chloroquine and hydroxychloroquine (Hydroxychloroquine and Ocular Toxicity: Recommendations on Screening 2009). The following recommendations relate to hydroxychloroquine, which is only rarely associated with toxicity.\n\nBefore treatment:\n\nAssess renal and liver function (adjust dose if impaired) Ask patient about visual impairment (not corrected by glasses). If impairment or eye disease present, assessment by an optometrist is advised and any abnormality should be referred to an ophthalmologist Record near visual acuity of each eye (with glasses where appropriate) using a standard reading chart Initiate hydroxychloroquine treatment if no abnormality detected (at a dose not exceeding hydroxychloroquine sulfate 6.5 mg/kg daily)\n\nDuring treatment:\n\nAsk patient about visual symptoms and monitor visual acuity annually using the standard reading chart Refer to ophthalmologist if visual acuity changes or if vision blurred and warn patient to seek prescribing doctor&#8217;s advice about stopping treatment If long-term treatment is required (more than 5 years), individual arrangement should be agreed with the local ophthalmologist",
                "html": "<p>A review group convened by the Royal College of Ophthalmologists has updated guidelines for screening to prevent ocular toxicity on long-term treatment with chloroquine and hydroxychloroquine (<i>Hydroxychloroquine and Ocular Toxicity: Recommendations on Screening 2009</i>). The following recommendations relate to hydroxychloroquine, which is only rarely associated with toxicity.</p><p>\r\n<i>Before treatment</i>:</p><ul>\r\n<li>Assess renal and liver function (adjust dose if impaired)</li>\r\n<li>Ask patient about visual impairment (not corrected by glasses). If impairment or eye disease present, assessment by an optometrist is advised and any abnormality should be referred to an ophthalmologist</li>\r\n<li>Record near visual acuity of each eye (with glasses where appropriate) using a standard reading chart</li>\r\n<li>Initiate hydroxychloroquine treatment if no abnormality detected (at a dose not exceeding hydroxychloroquine sulfate 6.5&#8239;mg/kg daily)</li>\r\n</ul><p>\r\n<i>During treatment:</i>\r\n</p><ul>\r\n<li>Ask patient about visual symptoms and monitor visual acuity annually using the standard reading chart</li>\r\n<li>Refer to ophthalmologist if visual acuity changes or if vision blurred and warn patient to seek prescribing doctor&#8217;s advice about stopping treatment</li>\r\n<li>If long-term treatment is required (more than 5 years), individual arrangement should be agreed with the local ophthalmologist</li>\r\n</ul>"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (chloroquine and hydroxychloroquine).\n\nConcurrent use of hepatotoxic drugs should be avoided.",
                "html": "<p>Appendix 1 (chloroquine and hydroxychloroquine).</p><p>Concurrent use of hepatotoxic drugs should be avoided.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Gastro-intestinal disturbances",
                        "html": "Gastro-intestinal disturbances",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "pruritus",
                        "html": "pruritus",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "rashes",
                        "html": "rashes",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "skin reactions",
                        "html": "skin reactions",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Convulsions",
                        "html": "Convulsions",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "discoloration of skin, nails, and mucous membranes",
                        "html": "discoloration of skin, nails, and mucous membranes",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "ECG changes",
                        "html": "ECG changes",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "hair depigmentation",
                        "html": "hair depigmentation",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "hair loss",
                        "html": "hair loss",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "keratopathy",
                        "html": "keratopathy",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "ototoxicity",
                        "html": "ototoxicity",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "retinal damage",
                        "html": "retinal damage",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "visual changes",
                        "html": "visual changes",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ],
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Acute generalised exanthematous pustulosis",
                        "html": "Acute generalised exanthematous pustulosis",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "agranulocytosis",
                        "html": "agranulocytosis",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "angioedema",
                        "html": "angioedema",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "aplastic anaemia",
                        "html": "aplastic anaemia",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "blood disorders",
                        "html": "blood disorders",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "cardiomyopathy",
                        "html": "cardiomyopathy",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "emotional disturbances",
                        "html": "emotional disturbances",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "exfoliative dermatitis",
                        "html": "exfoliative dermatitis",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "hepatic damage",
                        "html": "hepatic damage",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "mental changes",
                        "html": "mental changes",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "myopathy",
                        "html": "myopathy",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "neuromyopathy",
                        "html": "neuromyopathy",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "photosensitivity",
                        "html": "photosensitivity",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "psychosis",
                        "html": "psychosis",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "Stevens-Johnson syndrome",
                        "html": "Stevens-Johnson syndrome",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "thrombocytopenia",
                        "html": "thrombocytopenia",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Bronchospasm",
                        "html": "Bronchospasm",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "diffuse parenchymal lung disease",
                        "html": "diffuse parenchymal lung disease",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "drug rash with eosinophilia and systemic symptoms",
                        "html": "drug rash with eosinophilia and systemic symptoms",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "overdosageInformation": [
            {
                "type": "overdosageInformation",
                "textContent": "Hydroxychloroquine is very toxic in overdosage; overdosage is extremely hazardous and difficult to treat. Urgent advice from the National Poisons Information Service is essential. Life-threatening features include arrhythmias (which can have a very rapid onset) and convulsions (which can be intractable).",
                "html": "<p>Hydroxychloroquine is very toxic in overdosage; overdosage is extremely hazardous and difficult to treat. Urgent advice from the National Poisons Information Service is essential. Life-threatening features include arrhythmias (which can have a very rapid onset) and convulsions (which can be intractable).</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "It is not necessary to withdraw an antimalarial drug during pregnancy if the rheumatic disease is well controlled; however, the manufacturer of hydroxychloroquine advises avoiding use.",
                "html": "<p>It is not necessary to withdraw an antimalarial drug during pregnancy if the rheumatic disease is well controlled; however, the manufacturer of hydroxychloroquine advises avoiding use.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Present in breast milk and breast-feeding; should be avoided when they are used to treat rheumatic disease.\n\nAvoid&#8212;risk of toxicity in infant.",
                "html": "<p>Present in breast milk and breast-feeding; should be avoided when they are used to treat rheumatic disease.</p><p>Avoid&#8212;risk of toxicity in infant.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Caution in moderate to severe hepatic impairment.",
                "html": "<p>Caution in moderate to severe hepatic impairment.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises caution.",
                "html": "<p>Manufacturer advises caution.</p>"
            }
        ],
        "additionalMonitoring": [
            {
                "type": "additionalMonitoring",
                "textContent": "Monitoring of plasma-hydroxychloroquine concentration in severe renal impairment.",
                "html": "<p>Monitoring of plasma-hydroxychloroquine concentration in severe renal impairment.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Manufacturers recommend regular ophthalmological examination but the evidence of practical value is unsatisfactory (see advice of the Royal College of Ophthalmologists).",
                "html": "<p>Manufacturers recommend regular ophthalmological examination but the evidence of practical value is unsatisfactory (see advice of the Royal College of Ophthalmologists).</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "To avoid excessive dosage in obese patients, the dose of hydroxychloroquine should be calculated on the basis of ideal body-weight.",
                "html": "<p>To avoid excessive dosage in obese patients, the dose of hydroxychloroquine should be calculated on the basis of ideal body-weight.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "textContent": "Do not take antacids for at least 4 hours before or after hydroxychloroquine to reduce possible interference with hydroxychloroquine absorption.",
                "html": "<p>Do not take antacids for at least 4 hours before or after hydroxychloroquine to reduce possible interference with hydroxychloroquine absorption.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral solution",
                "oral suspension"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76794",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78421",
                "label": "Rheumatic disease, suppressing drugs",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78455",
                "label": "Corticosteroids, inflammatory disorders",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78614",
                "label": "Arthritis",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_982",
                "label": "Hydroxychloroquine",
                "type": "interaction"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78608",
                "label": "Acute porphyrias",
                "type": "treatmentSummary"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76794",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    }
}